Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela K Deem

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Chromosoma|January 18, 2012
Epigenetic regulation of genomic integrityAngela K Deem, Xuan Li, Jessica K Tyler
Gene|July 28, 2006
Prenylcysteine methylesterase in Arabidopsis thalianaAngela K Deem, Rebecca L Bultema, Dring N Crowell
Cancers|October 19, 2019
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?Sara Loponte, Sara Lovisa, Angela K Deem, et al.
Cancers|September 11, 2019
Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational ResearchAkira Inoue, Angela K Deem, Scott Kopetz, et al.
Molecular Cell|December 17, 2015
Translesion Polymerases Drive Microhomology-Mediated Break-Induced Replication Leading to Complex Chromosomal RearrangementsCynthia J Sakofsky, Sandeep Ayyar, Angela K Deem, et al.
The Plant Journal : for Cell and Molecular Biology|April 12, 2007
Arabidopsis thaliana plants possess a specific farnesylcysteine lyase that is involved in detoxification and recycling of farnesylcysteineDring N Crowell, David H Huizinga, Angela K Deem, et al.
Breast Cancer Research : BCR|January 20, 2026
Characterization of ESR1 alterations in patients with breast and gynecologic cancersGargi D Basu, Paige E Innis, Angela K Deem, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Cancer Research|November 7, 2020
Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic StressHideo Tomihara, Federica Carbone, Luigi Perelli, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Chromosoma|January 18, 2012
Epigenetic regulation of genomic integrityAngela K Deem, Xuan Li, Jessica K Tyler
Gene|July 28, 2006
Prenylcysteine methylesterase in Arabidopsis thalianaAngela K Deem, Rebecca L Bultema, Dring N Crowell
Cancers|October 19, 2019
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?Sara Loponte, Sara Lovisa, Angela K Deem, et al.
Cancers|September 11, 2019
Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational ResearchAkira Inoue, Angela K Deem, Scott Kopetz, et al.
Molecular Cell|December 17, 2015
Translesion Polymerases Drive Microhomology-Mediated Break-Induced Replication Leading to Complex Chromosomal RearrangementsCynthia J Sakofsky, Sandeep Ayyar, Angela K Deem, et al.
The Plant Journal : for Cell and Molecular Biology|April 12, 2007
Arabidopsis thaliana plants possess a specific farnesylcysteine lyase that is involved in detoxification and recycling of farnesylcysteineDring N Crowell, David H Huizinga, Angela K Deem, et al.
Breast Cancer Research : BCR|January 20, 2026
Characterization of ESR1 alterations in patients with breast and gynecologic cancersGargi D Basu, Paige E Innis, Angela K Deem, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Cancer Research|November 7, 2020
Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic StressHideo Tomihara, Federica Carbone, Luigi Perelli, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
Pageof 3